Q1 2021 Rigel Pharmaceuticals Inc Earnings Call Transcript
Greetings and welcome to Rigel pharmaceuticals financial conference call for the first quarter of 2021. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce our first speaker Dolly Vance, who's Rigel's Executive Vice President Corporate Affairs and General Counsel. Thank you. Ms. Vance, you may begin.
Welcome to our first quarter 2021 financial results in business update conference call. The financial press release for the first quarter was issued a short while ago and can be viewed along with the company Slides for this presentation in the news and events section of our investor relations page on our website at www.rigel.com. As a reminder, during today's call, we may make forward-looking statements regarding our financial outlook and our plans and timing for regulatory and product development.
These
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |